• Traitements

  • Traitements localisés : applications cliniques

  • Colon-rectum

Comparable survival benefit of local excision versus radical resection for 10- to 20-mm rectal neuroendocrine tumors

Menée à l'aide de données des registres américains des cancers portant sur 531 patients présentant une tumeur neurodocrine rectale de 10 à 20 mm, cette étude compare l'efficacité, du point de vue de la survie spécifique et de la survie globale, d'une résection radicale par rapport à une exérèse locale

Objective: The optimal surgical management for 10- to 20-mm rectal neuroendocrine tumors (RNET) is still a matter of debate. This study aimed to explore the optimal surgical approach for 10- to 20-mm RNET by comparing the outcomes between local excision and radical resection. Method: We extracted clinicopathological information of 10- to 20-mm RNET from the Surveillance, Epidemiology, and End Results (SEER) database. The 1:2 propensity score matching (PSM) method was used to balance the imbalanced baseline covariates (P < 0.05) between the local excision group and radical resection group. A Cox proportional hazards model was used to identify the risk factors associated with cancer-specific survival (CSS) and overall survival (OS). Result: A total of 531 RNET patients 10–20 mm in size were included. Patients receiving radical resection had larger tumor sizes (P < 0.001), higher T stages (P < 0.001), higher N stages (P < 0.001), higher M stages (P = 0.002) and higher grades (P = 0.041). For 10–20 mm RNET patients, radical resection had no survival benefit compared with local excision (CSS: HR = 2.048, 95% CI 0.553–7.576, P = 0.283; OS: HR = 1.090, 95% CI 0.535–2.219, P = 0.813). After 1:2 PSM, there was no significant difference between local excision and radical resection. Radical resection still had no survival benefit over local excision (CSS: HR = 0.449, 95% CI 0.050–4.022, P = 0.474; OS: HR = 1.408, 95% CI 0.488–4.061, P = 0.527). In a multivariate analysis of CSS, age 60 years old (P = 0.005), tumour size 14–20 mm (P = 0.011) and M1 stage (P < 0.001) were identified as independent prognostic factors for worse CSS. In multivariate analysis of OS, age>60 years (P

0.001), male sex (P = 0.007), black race (P = 0.016), and T2/T3/T4 stage (P = 0.007) were significantly associated with worse OS. N stage was not an independent predictive factor for CSS and OS. Conclusion: This study revealed that for 10- to 20-mm RNET patients, there was no survival benefit for radical resection compared with local excision, which suggested that local excision may be an adequate treatment for these patients.

European Journal of Surgical Oncology 2021

Voir le bulletin